2017
Topical drug-induced subacute cutaneous lupus erythematosus isolated to the hands
Ramachandran SM, Leventhal JS, Franco LG, Mir A, Walters RF, Franks AG. Topical drug-induced subacute cutaneous lupus erythematosus isolated to the hands. Lupus Science & Medicine 2017, 4: e000207. PMID: 28331627, PMCID: PMC5353283, DOI: 10.1136/lupus-2017-000207.Peer-Reviewed Original ResearchDrug-induced SCLECutaneous lupus erythematosusLupus erythematosusTopical terbinafineUnique presentationDrug-induced subacute cutaneous lupus erythematosusSSA/Ro antibodiesSubacute cutaneous lupus erythematosusDrug-induced formsPatient's unique presentationTopical antifungal creamAnti-Ro antibodiesVariable systemic involvementRo antibodiesOral agentsOral terbinafineSystemic involvementTopical medicationsErythematous lesionsPsoriasiform lesionsPhysical examinationHistological featuresAntifungal creamOccupational exposureDorsal hand
2015
Treatment of Scarring Alopecia in Discoid Variant of Chronic Cutaneous Lupus Erythematosus With Tacrolimus Lotion, 0.3%
Milam EC, Ramachandran S, Franks AG. Treatment of Scarring Alopecia in Discoid Variant of Chronic Cutaneous Lupus Erythematosus With Tacrolimus Lotion, 0.3%. JAMA Dermatology 2015, 151: 1113-1116. PMID: 26039539, DOI: 10.1001/jamadermatol.2015.1349.Peer-Reviewed Original ResearchConceptsDiscoid lupus erythematosusCutaneous lupus erythematosusLupus erythematosusScarring alopeciaHair regrowthChronic cutaneous lupus erythematosusOral antimalarial therapyPermanent scarring alopeciaAutoimmune inflammatory disorderFirst-line therapyLate-stage diseasePotential therapeutic optionAlcohol baseChronic variantsDiscoid variantOral antimalarialsIntralesional corticosteroidsDLE lesionsTherapeutic optionsInflammatory disordersAntimalarial therapyPermanent scarringRetrospective analysisLesion severityIrreversible alopecia